Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Novel drug combinations for the management of relapsed/refractory multiple myeloma.
Trends in prehospital delay in patients with acute myocardial infarction (from the Worcester Heart Attack Study).
See All 2 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Novel drug combinations for the management of relapsed/refractory multiple myeloma.
Usmani SZ, Lonial S. Novel drug combinations for the management of relapsed/refractory multiple myeloma. Clin Lymphoma Myeloma Leuk. 2014 Sep; 14 Suppl:S71-7.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Antineoplastic Combined Chemotherapy Protocols
Disease Management
Disease Progression
Histone Deacetylase Inhibitors
Humans
Multiple Myeloma
Oligopeptides
Proteasome Inhibitors
Recurrence
Thalidomide
authors with profiles
Saad Usmani MD